Skip to main content
. 2009 Jan 28;24(Suppl 1):S148–S155. doi: 10.3346/jkms.2009.24.S1.S148

Table 3.

Immunologic characteristics before initiation of desensitization protocol

graphic file with name jkms-24-S148-i003.jpg

*Patients 5 and 8 were previously crossmatch-positive by FCM for both T cells and B cells; Previous DSA detected by PRA.

M, male; F, female; Prev TX, previous transplantation; Prev TF, previous transfusion; AHG-CDC, antihuman globulin-enhanced complement-dependent cytotoxicity; FCM, flow-cytometry; PRA, panel-reactive antibody; DSA, donor-specific antibody.